The global spinal device and biologics market is expected to grow at a compound annual growth rate of 6.9 percent until 2015, according to the latest analysis by Reporterlink.
One of the key factors contributing to this market growth is the development of better and longer-lasting implants. The market has also been witnessing an increase in the number of strategic alliances. However, the shortage of healthcare workers and high wages could pose a challenge to the growth of this market.
Companies dominating this market include DePuy, Medtronic, Stryker and Synthes.